Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin DiFrancesco

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 3, 2017
Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspiratesAndrew J Ocque, Colleen E Hagler, Robin DiFrancesco, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratoriesDiane T Holland, Robin DiFrancesco, Judith Stone, et al.
Therapeutic Drug Monitoring|March 5, 2019
Sources of Variability and Accuracy of Performance Assessment in the Clinical Pharmacology Quality Assurance Proficiency Testing Program for AntiretroviralsRichard W Browne, Susan L Rosenkranz, Yan Wang, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 31, 2025
LC-MS/MS method for quantifying the HIV-1 broadly neutralizing antibody PGT 121.414.LS in human serumConnor E Gould, Qing Ma, Raymond Cha, et al.
Pharmacotherapy|July 30, 2003
Effects of didanosine formulations on the pharmacokinetics of amprenavirMark J Shelton, Angela A Giovanniello, Denise Cloen, et al.
AIDS (London, England)|April 11, 2006
Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavirTroy M Martin, Gene D Morse, Jaclynn Kurpewski, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 3, 2007
Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometryRobin DiFrancesco, Robert DiCenzo, Glorimar Vicente, et al.
Drugs in R&D|September 7, 2017
Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309sJennifer J Kiser, Darlene Lu, Susan L Rosenkranz, et al.
Therapeutic Drug Monitoring|February 17, 2007
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and applicationKim Keil, Jill Hochreitter, Robin DiFrancesco, et al.
Therapeutic Drug Monitoring|March 19, 2013
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146Xinyan Zhang, Camlin Tierney, Mary Albrecht, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 3, 2017
Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspiratesAndrew J Ocque, Colleen E Hagler, Robin DiFrancesco, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratoriesDiane T Holland, Robin DiFrancesco, Judith Stone, et al.
Therapeutic Drug Monitoring|March 5, 2019
Sources of Variability and Accuracy of Performance Assessment in the Clinical Pharmacology Quality Assurance Proficiency Testing Program for AntiretroviralsRichard W Browne, Susan L Rosenkranz, Yan Wang, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 31, 2025
LC-MS/MS method for quantifying the HIV-1 broadly neutralizing antibody PGT 121.414.LS in human serumConnor E Gould, Qing Ma, Raymond Cha, et al.
Pharmacotherapy|July 30, 2003
Effects of didanosine formulations on the pharmacokinetics of amprenavirMark J Shelton, Angela A Giovanniello, Denise Cloen, et al.
AIDS (London, England)|April 11, 2006
Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavirTroy M Martin, Gene D Morse, Jaclynn Kurpewski, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 3, 2007
Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometryRobin DiFrancesco, Robert DiCenzo, Glorimar Vicente, et al.
Drugs in R&D|September 7, 2017
Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309sJennifer J Kiser, Darlene Lu, Susan L Rosenkranz, et al.
Therapeutic Drug Monitoring|February 17, 2007
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and applicationKim Keil, Jill Hochreitter, Robin DiFrancesco, et al.
Therapeutic Drug Monitoring|March 19, 2013
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146Xinyan Zhang, Camlin Tierney, Mary Albrecht, et al.
Pageof 6